ZYMO RESEARCH Trademark
ZYMO RESEARCH is a USPTO trademark filed by Zymo Research Corporation. Status: Registered.
Trademark Facts
| Mark | ZYMO RESEARCH |
|---|---|
| Serial Number | 90245561 |
| Registration Number | 6647847 |
| Status | Registered |
| Filing Date | 2020-10-09 |
| Registration Date | 2022-02-15 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 009 (Electronics & Software), 042 (Software & IT) |
| Owner | Zymo Research Corporation |
| Attorney of Record | Jonathan A Claypool |
| Prosecution Events | 30 |
| Latest Event | R.PR on 2022-02-15 |
Goods & Services
Class 001: Biotechnology research products for research use, namely, reagents and chemicals for use in industry and science, buffer solutions for use in molecular and analytical chemistry, proteins and enzymes for scientific research and pheromones for use in expression, amplification, modification, purification, isolation, and preparation of nucleic acids and proteins for scientific research and analysis; biological samples, namely, bacteria, yeast, fungi, or mammalian cells for scientific research and analysis; all sold individually and as a part of kits; Class 009: Biotechnology research products, instruments, and devices for research use, namely, chromatographic columns, for use in expression, amplification, modification, purification, isolation, and preparation of nucleic acids and proteins for scientific research and analysis, sold individually and as a part of kits; Class 042: Medical and scientific research services, for the analysis of genomics, epigenomics, transcriptomics, and microbiomics for research and medical uses, namely, Genome-Wide, whole-genome, or global DNA Methylome (Methylation) Analysis, genome-wide or global DNA hydroxymethylome (hydroxymethylation) Analysis, Targeted Sequencing for DNA Methylation Analysis, RNA Transcriptome (RNA-Seq, Micro RNA-Seq) Analysis, Chromatin (ChIP-Seq, ATAC-Seq) Analysis, Microbiome (16S, ITS, 18S, Shotgun metagenome, and metatranscriptome) Analysis, Cancer Analysis, namely, Bladder Cancer Analysis, and Epigenetic Aging Clock Analysis, namely, Biological Age Analysis